PDF(Pubmed)
Abstract：
UNASSIGNED: We report a case of advanced testicular cancer cured by early and appropriate resumption of chemotherapy even after COVID-19 infection during induction chemotherapy.
UNASSIGNED: The patient was a healthy 36-year-old male. The diagnosis was a stage IIIB nonseminoma (pT2N2M1a). On day 14 of the first chemotherapy cycle, the patient was diagnosed with mild COVID-19. The second chemotherapy cycle was initiated with a 1-day delay (on day 10 after the COVID-19 diagnosis). The patient achieved remission with minimal postponement of chemotherapy.
UNASSIGNED: Only a few case reports have described the resumption of anticancer chemotherapy in patients with COVID-19. In deciding when to resume chemotherapy after COVID-19 infection, it is essential to consider factors such as cancer type, progression, and severity of COVID-19 and should be tailored to individual patient needs.
UNASSIGNED: The patient was a healthy 36-year-old male. The diagnosis was a stage IIIB nonseminoma (pT2N2M1a). On day 14 of the first chemotherapy cycle, the patient was diagnosed with mild COVID-19. The second chemotherapy cycle was initiated with a 1-day delay (on day 10 after the COVID-19 diagnosis). The patient achieved remission with minimal postponement of chemotherapy.
UNASSIGNED: Only a few case reports have described the resumption of anticancer chemotherapy in patients with COVID-19. In deciding when to resume chemotherapy after COVID-19 infection, it is essential to consider factors such as cancer type, progression, and severity of COVID-19 and should be tailored to individual patient needs.
摘要：
■我们报告了一例晚期睾丸癌，即使在诱导化疗期间感染COVID-19后，也通过早期适当恢复化疗治愈。
■患者是一名健康的36岁男性。诊断为IIIB期非精原细胞瘤（pT2N2M1a）。在第一个化疗周期的第14天，患者被诊断为轻度COVID-19。第二个化疗周期延迟1天开始(在COVID-19诊断后第10天)。患者在最小程度推迟化疗的情况下获得缓解。
■只有少数病例报告描述了COVID-19患者恢复抗癌化疗。在决定COVID-19感染后何时恢复化疗时，必须考虑癌症类型等因素，programming,和COVID-19的严重程度，应根据个体患者的需求量身定制。
■患者是一名健康的36岁男性。诊断为IIIB期非精原细胞瘤（pT2N2M1a）。在第一个化疗周期的第14天，患者被诊断为轻度COVID-19。第二个化疗周期延迟1天开始(在COVID-19诊断后第10天)。患者在最小程度推迟化疗的情况下获得缓解。
■只有少数病例报告描述了COVID-19患者恢复抗癌化疗。在决定COVID-19感染后何时恢复化疗时，必须考虑癌症类型等因素，programming,和COVID-19的严重程度，应根据个体患者的需求量身定制。
